Navigation Links
ISTA Pharmaceuticals to Present at the Cowen & Company 28th Annual Health Care Conference
Date:3/12/2008

IRVINE, Calif., March 12 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will present at the Cowen & Company 28th Annual Health Care Conference at 3:55 p.m. Eastern Daylight Time on March 18, 2008, at the Boston Marriott Copley Place Hotel in Boston, MA.

ISTA's President and Chief Executive Officer, Vicente Anido, Jr., Ph.D., will provide an update on the Company's commercial and clinical progress. To access the live audio broadcast or the subsequent archived recording log onto http://www.istavision.com. Please connect to the website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.

ABOUT ISTA PHARMACEUTICALS

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. SGX Pharmaceuticals Announces Fourth Quarter and Full Year Financial Results
2. Onyx Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
3. Idenix Pharmaceuticals to Present at the Eleventh Annual Lehman Brothers Global Healthcare Conference
4. Drinking Water Association Discusses Pharmaceuticals in Water
5. Genesis Pharmaceuticals Changes Auditors
6. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
7. Statement from American Water Works Association on Associated Press Story on Pharmaceuticals in Drinking Water
8. Vion Pharmaceuticals Regains NASDAQ Listing Compliance
9. NPS Pharmaceuticals to Report 2007 Financial Results
10. Trubion Pharmaceuticals Announces Dates for Fourth-Quarter and Year-End 2007 Earnings Conference Call
11. Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...mice, disks placed under the skin kill tumor cells...althDay News) -- A cancer vaccine delivered in a f...in mice, a new study reports. , The method uses...are loaded with tumor-specific antigens and implan...to attack tumors. The Harvard University scientist...
(Date:11/25/2009)... BioSpace.com, the premier r...unveiled the third edition of the BioForest™... Englewood, CO (Vocus) November 25, 2009 --...ce careers and information, unveiled the third edi...morning., , , , ,This regional campaign is a prom...
(Date:11/25/2009)..., SALTLAKECITY,Nov.25/PRNewswire/--dazzlesmile,...C www.optimalhealthscience.com havefileda67-pagefe...azoogle.com,Inc.,JesseWillms,FarendServicesLimited...ththeUnitedStatesDistrictCourtfortheDistrictofUtah...gofdazzlesmile(TM)brandedteethwhiteningproducts,vi...
(Date:11/25/2009)... HOUSTON - Two signaling pathways essential to nor... epidermal growth factor receptor (EGFR) pathways ...asion and metastasis, researchers from The Univers...n the Nov. 25 issue of Molecular Cell . , This ...naling components known to correlate with invasive...
(Date:11/25/2009)...This press release is available in French . , ,...nologies are about to enter the marketplace, thank...imited Partnership (Univalor) and Cognitive Sensin... based in Montreal. , Univalor, which commercial... its affiliated institutions, and CSI have announc...
Breaking Medicine News(10 mins):Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2
... 40%, to 56,000 new cases annually, CDC researcher...) -- The number of Americans newly infected with H...at was previously assumed, U.S.health officials ha..., Using the new method, researchers at the U.S. Ce...
...aw Firm Offers Assistance, Information to People A... Houston, TX (PRWEB) August 2, 2008 ...leman announce the launch of a http://www.tysabri...ysabri, a drug used to treat multiple sclerosis (M...
... new infections in 2006,follows nearly two-year de...w HIV infection,figures scheduled to be released o...and Prevention (CDC) are expected to increase the ...n ongoing,increase in the annual estimated infecti...
...Nasdaq: GXDX ), a specialized laboratory services... and Laurence R. McCarthy, Ph.D. to its Board of,D...am has been elected to,serve as a Class I director... elected to serve as a Class II director of,Genopt...
...ogram launched locally to help people manage the d...hospital admissions among participants. , The fir...s & Balances encourages people with diabetes to co...-cholesterol, an eye exam, and screening for kidne...
...ke reactions to nonionic iodinated contrast materi...nd can be treated safely with commonly used medica...earchers at the University of Michigan Hospitals i...st material to patients and some of these reaction...
Other Medicine News:Health News:Number of New U.S. HIV Infections Gets Revised Upwards 2Health News:Tysabri Lawyers Pulaski & Middleman Launch Web Resource Center for Patients Suffering from Tysabri Side Effects 2Health News:New HIV Infection Figures from CDC to be Announced on Aug. 3 Underscore Need for National AIDS Strategy for the U.S. 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 3Health News:Innovative diabetes program in Bloomington-Normal, Ill., a success 2Health News:Allergic-like reactions to iodinated contrast material treated safely with commonly used medications 2
(Date:11/25/2009)...ordingtoMillenniumResearchGroup(MRG),theglobalauth...ly$3billionUSmarketfortraumafixationdeviceswillcon...erecenteconomicslowdown.MRG,s USMarketsforTraumaDe...hlydynamicoverthenextfiveyears,withcompetitorsintr...gmentsofthetraumafixationmarket,fuelingmarketgrowt...
(Date:11/25/2009)...empraPharmaceuticalsInc.todayannouncedthatPrabhava...lpresentatthePiperJaffray21stAnnualHealthCareConfe...ceHotelinNewYorkCity.Dr.Fernandeswillprovideanover...ramsforthetreatmentofdrug-resistantpathogensinclud...Foundedin2006,CempraPharmaceuticalsisaprivately-he...
(Date:11/25/2009)...ker.comannouncesthatanewmarketresearchreportisavai...-USMarketTrends&Analysis http://www.reportlin...ket-Trends--Analysis.html ,, TheUSintranasaldr...icapplicationsfromthedeliveryofconventionallocalth...ugs.Thefutureofthetechnologyhingesontotheeffective...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 1Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 2Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 3H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 1H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 1Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 3
...uced risk of death by 13% (P=0.08), despite inclus...mara therapy , , - In a separate censored ana...o Femara, reduction in risk of death was 19% , ...IG 1-98 trial reinforces starting with Femara as t... , EAST HANOVER, N.J., Dec. 11 New long-term d...
...cember 11 AFFiRiS has started,pre-clinical develo... as,PD01, can be used to target a specific protein...s degenerative neurological disease. Excellent pro...ed the company to file a patent,application and pr...tive,results from external assessments impelled th...
Other Medicine Technology:Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 2Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 3Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 4Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 5Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 6Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 7Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 8AFFiRiS Begins Development of a Parkinson's Vaccine 2AFFiRiS Begins Development of a Parkinson's Vaccine 3
Sterile Coil Packed Pediatric Suction Catheters with SAFE-T-VAC Valve
Sterile Suction Catheters without Control Valve
Sterile Single Loop Suction Catheters with TOUCH-TROL Valve
Catheter Suction 14FR Sterile W/Control Valve
Medicine Products: